Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Tenaya Therapeutics Inc (TNYA)

Tenaya Therapeutics Inc (TNYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 288,161
  • Shares Outstanding, K 78,518
  • Annual Sales, $ 0 K
  • Annual Income, $ -124,080 K
  • 60-Month Beta 2.43
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.68
Trade TNYA with:

Options Overview Details

View History
  • Implied Volatility 244.13% ( +77.78%)
  • Historical Volatility 89.73%
  • IV Percentile 92%
  • IV Rank 38.22%
  • IV High 616.65% on 10/17/23
  • IV Low 13.65% on 07/12/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 43
  • Volume Avg (30-Day) 38
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 807
  • Open Int (30-Day) 1,786

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.40
  • Number of Estimates 7
  • High Estimate -0.28
  • Low Estimate -0.49
  • Prior Year -0.45
  • Growth Rate Est. (year over year) +11.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.58 +45.74%
on 06/26/24
3.82 -1.57%
on 07/17/24
+0.64 (+20.51%)
since 06/21/24
3-Month
2.58 +45.74%
on 06/26/24
4.96 -24.19%
on 05/03/24
-0.69 (-15.51%)
since 04/23/24
52-Week
1.66 +126.51%
on 10/27/23
7.01 -46.36%
on 03/05/24
-1.44 (-27.69%)
since 07/21/23

Most Recent Stories

More News
Why This Nasdaq Stock Caught Fire This Week

A wave of bargain buying benefited the gene therapy company's shares this week.

BLU : 14.74 (unch)
RXDX : 199.92 (+0.09%)
TNYA : 3.76 (+2.45%)
Tenaya Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

Received State Licensing to Enable cGMP Manufacturing of Drug Product TN-201 and TN-301 IND Submissions on Track for Second Half 2022 Presented...

TNYA : 3.76 (+2.45%)
Tenaya Therapeutics Publishes Preclinical Data in Science Translational Medicine Detailing Discovery of HDAC6 Inhibitor for Treatment of Heart Failure

Tenaya’s Precision Medicine Platform Used to Identify HDAC6 Target Using Phenotypic Screening and Machine Learning Algorithms Tenaya’s HDAC6 Inhibitor...

TNYA : 3.76 (+2.45%)
Tenaya Therapeutics Launches Operations of New Genetic Medicines Manufacturing Center to Support the Development of Potentially First-In-Class Cardiovascular Therapeutics

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, today announced...

TNYA : 3.76 (+2.45%)
Tenaya Therapeutics to Present Preclinical Data on TN-301 HDAC6 Inhibitor at European Society of Cardiology Heart Failure 2022 Conference

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced that...

TNYA : 3.76 (+2.45%)
Tenaya Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today...

TNYA : 3.76 (+2.45%)
Tenaya Therapeutics to Present Preclinical Data on Gene Therapy Programs and Platform Capabilities at the American Society of Gene and Cell Therapy 25th Annual Meeting

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced that...

TNYA : 3.76 (+2.45%)
Tenaya Therapeutics to Present Preclinical Data on TN-401 PKP2 Gene Therapy Program at Heart Rhythm 2022

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced that...

TNYA : 3.76 (+2.45%)
Tenaya Therapeutics to Participate in Upcoming Investor Conferences

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, today announced...

TNYA : 3.76 (+2.45%)
Tenaya Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Updates

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today...

TNYA : 3.76 (+2.45%)

Business Summary

Tenaya Therapeutics Inc. is a biotechnology company. It discovers, develop and deliver curative therapies which address the underlying causes of heart disease. The company's product platform consist Gene Therapy, Cellular Regeneration and Precision Medicine. Tenaya Therapeutics Inc. is based in SOUTH...

See More

Key Turning Points

3rd Resistance Point 4.02
2nd Resistance Point 3.91
1st Resistance Point 3.84
Last Price 3.76
1st Support Level 3.66
2nd Support Level 3.55
3rd Support Level 3.48

See More

52-Week High 7.01
Fibonacci 61.8% 4.97
Fibonacci 50% 4.34
Last Price 3.76
Fibonacci 38.2% 3.70
52-Week Low 1.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar